Results 51 to 60 of about 2,957 (202)

Comparison of lethality of crude venoms and toxin fractions (TF) of four elapid snakes.

open access: yes, 2016
Comparison of lethality of crude venoms and toxin fractions (TF) of four elapid snakes.
Sukanya Eursakun (3174869)   +8 more
core   +1 more source

No gain from pain: Lack of nociceptor activation suggests no adaptation for defence in the evolution of European viper venoms

open access: yesFunctional Ecology, Volume 40, Issue 10, Page 3048-3062, October 2026.
Read the free Plain Language Summary for this article on the Journal blog. Abstract Snake venoms show variability in composition at all taxonomic levels, both within and between species, and the selective pressures underlying this variation have long been debated.
Bálint Üveges   +17 more
wiley   +1 more source

Investigating Snake-Venom-Induced Dermonecrosis and Inflammation Using an Ex Vivo Human Skin Model

open access: yesToxins
Snakebite envenoming is a neglected tropical disease that causes >100,000 deaths and >400,000 cases of morbidity annually. Despite the use of mouse models, severe local envenoming, defined by morbidity-causing local tissue necrosis, remains poorly ...
Jaffer Alsolaiss   +7 more
doaj   +1 more source

A Simple and Novel Strategy for the Production of a Pan-specific Antiserum against Elapid Snakes of Asia.

open access: yesPLoS Neglected Tropical Diseases, 2016
Snakebite envenomation is a serious medical problem in many tropical developing countries and was considered by WHO as a neglected tropical disease.
Kavi Ratanabanangkoon   +8 more
doaj   +1 more source

In vivo neutralization of 16 heterologous elapid venoms by ‘pan-specific’ antiserum.

open access: yes, 2016
In vivo neutralization of 16 heterologous elapid venoms by ‘pan-specific’ antiserum.
Sukanya Eursakun (3174869)   +8 more
core   +1 more source

Immunological Cross‐Reactivity and Neutralizing Efficacy of Antivenom Against Five Medically Important Iranian Viper Venoms

open access: yesVeterinary Medicine and Science, Volume 12, Issue 5, September 2026.
Investigating Iranian viper venoms reveals compositional and antigenic diversity impacting antivenom efficacy. The study highlights the need to incorporate both broadly cross‐reactive and specifically under‐represented venoms into immunization mixtures to optimize paraspecific protection strategies.
Sedigheh Khamehchian   +4 more
wiley   +1 more source

In vivo neutralization of 11 homologous elapid venoms by ‘pan-specific’ antiserum.

open access: yes, 2016
In vivo neutralization of 11 homologous elapid venoms by ‘pan-specific’ antiserum.
Sukanya Eursakun (3174869)   +8 more
core   +1 more source

Elapid crude venoms/toxin fractions used in the immunization of horses.

open access: yes, 2016
Elapid crude venoms/toxin fractions used in the immunization of horses.
Sukanya Eursakun (3174869)   +8 more
core   +1 more source

Brightfield microscopy images of RPTEC/TERT1 cells in response to three different venoms, which were used to quantify the cell surface area.

open access: yes, 2023
Conditions shown for three different venoms: cytotoxic viper, cytotoxic elapid and non-cytotoxic elapid. Top row represents the ‘training’ of the software to differentiate cell populations (red dots) from the ‘empty well area’ (green dots) using a simple
Nicholas R. Casewell (7062380)   +8 more
core   +1 more source

Engineering Antivenom: Research Progress and Future Directions in Snakebite Envenoming Therapy

open access: yesAnnals of the New York Academy of Sciences, Volume 1562, Issue 1, August 2026.
Snakebite envenoming therapy is evolving from plasma‐derived antivenoms toward rationally engineered therapeutics. Advances in toxicovenomics, structural biology, antibody engineering, computational protein design, recombinant expression, small‐molecule inhibitors, and diagnostics are enabling toxin‐centric development of safer, more effective, and ...
Andreas H. Laustsen
wiley   +1 more source

Home - About - Disclaimer - Privacy